A panel advising the European Union's drug regulator voted to endorse Pfizer's (PFE - News) Inlyta drug to treat kidney cancer. The FDA approved Inlyta for use in the U.S. in January. The committee ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results